Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04655443 · ClinicalTrials.gov registry record
Risk Factors That Contribute to the Maintenance of Sinus Rhythm
A clinical trial, sponsored by Danbury Hospital.
- Terminated
- Registry status
- 77
- Enrollment target
NCT04655443: Clinical Trial study, sponsored by Danbury Hospital.
NCT04655443 is a clinical trial that was terminated before completion, run by Danbury Hospital. The registered enrollment target is 77 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04655443 was terminated before completion, sponsored by Danbury Hospital.
- TERMINATED
- Registry status
- 77 participants
- Enrollment target
Study Summary
This is a prospective clinical research study. The objective of this study is to evaluate if clinical risk factors as well as structural features on echocardiography affect the maintenance of sinus rhythm after electrical cardioversion at 30 days. The investigators anticipate 140 patients to be enrolled in the study.
Primary Outcome
Left ventricular ejection fraction, left ventricular size, left ventricular hypertrophy, left atrial volume index, mitral valve early diastolic inflow velocity E, mitral valve tissue Doppler velocity e', E/e' ratio and pulmonary arterial pressure will be collected from transthoracic echocardiography findings in medical record. Left atrial size, left atrial appendage ejection fraction, left atrial appendage exit velocity, pulmonary venous flow with S/D ratio, and presence of spontaneous echo cont
Interventions
- OTHER Standard Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2017-08-29 |
| Est. Completion | 2021-02-03 |
Why NCT04655443 stopped before completion
NCT04655443 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 77 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Standard Care is the first listed.
NCT04655443 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04655443 about?
NCT04655443 is a clinical study titled "Risk Factors That Contribute to the Maintenance of Sinus Rhythm". This is a prospective clinical research study. The objective of this study is to evaluate if clinical risk factors as well as structural features on echocardiography affect the maintenance of sinus rhythm after electrical cardioversion at 30 days. The investigators anticipate 140 patients to be enro...
What is the current status of trial NCT04655443?
This trial is currently terminated. The enrollment target is 77 participants. The study started on 2017-08-29. Estimated completion is 2021-02-03.
What interventions are being tested in trial NCT04655443?
The interventions under investigation include: Standard Care (OTHER).
Who is sponsoring clinical trial NCT04655443?
This trial is sponsored by Danbury Hospital, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI